New Study Demonstrates Avenda Health’s Unfold AI to Better Predict Focal Therapy Success by 77% Percent as Compared to Standard Methods

A new UCLA study found Unfold AI’s precise prediction of prostate margins significantly impacts the success of focal therapy treatments CULVER CITY, Calif., May 8, 2024 /PRNewswire/ — Avenda Health, an AI healthcare company creating the future of personalized prostate cancer care,…

Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks